Test Discontinuation // Select WES + CMA and WES + mtDNA
Simplifying Ordering and Billing for Whole Exome Sequencing We know your testing choices directly shape how you guide patients and families. To make ordering…
Product Updates
Test Discontinuation // Pyrosequencing
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our…
Test Update // Report Improvements: Whole Genome & Exome Sequencing
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine…
Test Update // Chromosomal Microarray Analysis
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine…
Test Update // Relaunch of BluePrint Panel
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine…
Test Launch // Whole Genome Sequencing Reanalysis
Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu…
Test Update // Pausing COVID-19 Testing Services
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine…
Test Update // Cytogenetics Test Discontinuation
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our…
Test Launch // Whole Exome Sequencing & Whole Genome Sequencing (Rapid, Proband, & Duo)
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine…
Test Update // Single-gene Test Discontinuation
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our…
Test Launch // Rapid Whole Genome Sequencing
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner, as we continually upgrade and refine our…
Test Update // Global MAPS® (CSF)
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine…
Test Update // Whole Genome Sequencing
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our…
Test Update // Whole Exome Sequencing
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine…
Test Update // Whole Exome Sequencing
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine…
Test Update // PreSeekTM
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine…
Test Update // GeneAware
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine…
Test Discontinuation // Cytogenetics
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine…
Test Discontinuation // Biochemical
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our…
Temporary Test Discontinuation // CMA
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine…
Test Discontinuation // Overgrowth Panel
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our…
Test Discontinuations // Hereditary Cancer Single Gene Panels
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our…
Test Discontinuation // ClariFind
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our…
Test Update // Whole Exome Sequencing Reanalysis
Effective December 30, 2022, Baylor Genetics updated our policy for Whole Exome Sequencing (WES) Reanalysis, test code 1900. The update includes the first reanalysis to be…
Test Updates // Oncology // FISH Panel Probes (Dec 2019)
Dear Valued Clients, Effective December 16, 2019, in a continuing effort to optimize our offerings, Baylor Genetics has updated four FISH panels and will…
Test Discontinuations // Molecular
Dear Valued Clients, Effective November 1, 2019 in a continuing effort to optimize our offerings, these changes will be made. The following test codes…
Test Discontinuations // Cyto-Biochemical
Dear Valued Clients, Effective January 29, 2020 in a continuing effort to optimize our offerings, these changes will be made. The following test codes…
Test Updates // Oncology // FISH Panel Probes (October 2019)
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our…
Test Updates // Oncology // FISH Panel Probes
Dear Valued Clients, Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our…
Test Discontinuations // Biochemical
Dear Valued Clients, Effective May 8, 2019, in a continuing effort to optimize our offerings, these changes will be made. The following test codes will…
Test Updates Memorandum – Oncology
EFFECTIVE APRIL 16, 2018 THE FOLLOWING TEST UPDATE(S) WILL OCCUR: • Due to the limited clinical utility of assessing the SBDS gene for hereditary…
Test Updates Memorandum – Biochemical
EFFECTIVE IMMEDIATELY, THE FOLLOWING TEST UPDATE(S) WILL OCCUR: Orotic Acid/Orotidine Determination – Urine (Test code 4210) Due to the unavailability of a key reagent,…
Test Launch Memorandum // ClariFind
When it comes to cancer treatment, “one size fits all” doesn’t necessarily fit all. For that reason, Baylor Genetics offers a wide range of…
Test Discontinuation Memorandum – Tumor Analysis
Effective immediately, the following test code(s) will be discontinued: PIK3CA Mutation Detection (Test code 9035) An alternative testing option offered by Baylor Genetics is…
Test Updates Memorandum – Tumor Analysis
Effective immediately, the following test update(s) will occur: NPM1 Mutation by PCR and Fragment Analysis (test code 9005) has been updated by ARUP to…
Test Updates Memorandum
Effective January 9th, 2018, the following test updates will occur: Test Updates Our current SMN1 deletion analysis (test code 6059) will now include the…
Test Discontinuations Memorandum – Cancer
Effective November 29, 2017 in a continuing effort to optimize our offerings, these changes will be made. The following test code(s) will be discontinued:…
Test Discontinuations Memorandum – Cancer
Effective November 29, 2017, in a continuing effort to optimize our offerings, these changes will be made. Test updates Cancer Chromosomal Microarray Analysis –…
Test Discontinuations Memorandum – Biochemical
Effective August 31, 2017, in a continuing effort to optimize our offerings, these changes will be made. The following test code(s) will be discontinued:…
Test Updates Memorandum – Biochemical
Effective August 31, 2017, in a continuing effort to optimize our offerings, these changes will be made. The turnaround time (TAT) for the following…
Test Reporting Updates Memorandum – Prenatal Chromosomal Microarray Analysis
Effective July 5, 2017, in a continuing effort to optimize our offerings, the following changes will be made to the prenatal Chromosomal Microarray Analysis…
Test Reporting Updates Memorandum – Exome
In a continuing effort to optimize our offerings, the below detailed changes will be made to our exome platform offerings effective July 3, 2017.…
Test Discontinuations Memorandum – Biochemical
In a continuing effort to optimize our offerings, the following changes will be made. Effective May 29, 2017 The following test codes will be…
Test Updates Memorandum – Single Gene Cancer Tests
Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and…
Test Discontinuations Memorandum – Single Gene Cancer Tests
Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and…
Test Updates Memorandum – Biochemical
In a continuing effort to optimize our offerings, the following changes will be made. Effective immediately The CPT codes and insurance prices for the…
Test Discontinuation Memorandum
Effective February 27, 2017, in a continuing effort to optimize our offerings, these changes will be made. The following test code will be discontinued:…
Test Updates Memorandum – Test Code 4210
Due to a widespread commercial shortage of a key reagent, we are unable to provide testing of orotidine in the following test: Orotic Acid/Orotidine…
Test Updates Memorandum
Effective December 12, 2016, in a continuing effort to optimize our offerings, these changes will be made. The TAT for the following test code…
Test Discontinuation Memorandum
Effective December 12, 2016, in a continuing effort to optimize our offerings, these changes will be made. The following test codes will be discontinued:…
Test Discontinuation Memorandum
Effective August 31, 2016, in a continuing effort to optimize our offerings, these changes will be made. The following will be discontinued: Counsyl Universal…
Test Discontinuation Memorandum
Effective August 31 2016, in a continuing effort to optimize our offerings, these changes will be made. The following will be discontinued: Alpha-Galactosidase A…
Test Discontinuations Memorandum – Mitochondrial
Effective August 16, 2016, in a continuing effort to optimize our offerings, these changes will be made. The following will be discontinued. Single gene…
Test Updates Memorandum – Mitochondrial
Effective August 16, 2016, in a continuing effort to optimize our offerings, these changes will be made. The following panels will be updated by…
Test Discontinuation Memorandum
Effective May 9, 2016, Baylor Miraca Genetics Laboratories (BMGL) will discontinue the following tests: Test code 6055 – Spinocerebellar Ataxia Type 10 Repeat Expansion…
Test Discontinuation Memorandum
Effective December 21, 2015, Baylor Miraca Genetics Laboratories (BMGL) will discontinue the following tests: Test code 6001 – Ashkenazic Genetic Disease Panel Test code…
Test Discontinuation Memorandum
Effective December 17, 2015, Baylor Miraca Genetics Laboratories (BMGL) will make the following modifications to its test menu: Test code 9506 (Chromosomal Microarray Analysis…
Test Discontinuation Memorandum
Effective December 17, 2015, Baylor Miraca Genetics Laboratories (BMGL) will discontinue the following panels: Test code 6725 – HNPCC Comprehensive Panel – Sequence &…
Test Updates Memorandum
Effective December 9, 2015, Baylor Miraca Genetics Laboratories (BMGL) will rename the following tests: The Cancer Gene Mutation Panel Version 2 (test code 9705)…
Test Discontinuation Memorandum
Effective December 9, 2015, Baylor Miraca Genetics Laboratories (BMGL) will discontinue the following test: Test code 6084 – DMD Sequence Analysis For alternative testing,…
Test Discontinuation Memorandum
Effective December 9, 2015, Baylor Miraca Genetics Laboratories (BMGL) will make the following modifications to its test menu: Test code 9126 (KRAS Mutation Analysis…
Test Discontinuation Memorandum
Effective August 10, 2015, Baylor Miraca Genetics Labortories will discontinue the following test: Test code 9310 – UGT1A1 TA Repeat Analysis
Test Update Memorandum
Baylor Miraca Genetics Laboratories (BMGL) is pleased to announce the GeneAware version 2 (v2) Ashkenazi Jewish panels, which now include over 35 genes analyzed…
Test Discontinuation Memorandum
Effective August 3, 2015, Baylor Miraca Genetics Laboratories (BMGL) will begin performing BRCA1 & BRCA2 sequencing analysis as an in-house test. As a result,…
Test Discontinuation Memorandum
Effective immediately, Baylor Miraca Genetics Laboratories will discontinue the following test: Test code 9610 – Cancer Exome Sequencing The following test codes may be…
Test Update Memorandum
The Baylor Miraca Genetics Laboratories (BMGL) is pleased to announce that effective May 26, 2015, the GeneAware carrier screen will now include over 150…
Test Discontinuation Memorandum
Effective April 13, 2015, Baylor Miraca Genetics Laboratories will discontinue the following tests: Test Code: 6685 – TPMT Sequence Analysis Test Code: 6870 –…
Test Discontinuation Memorandum
Effective March 18, 2015, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue the following tests: Test Code: 2335 – FBN1 Sequence…
Test Updates Memorandum
Effective December 20, 2014, the whole exome sequencing tests offered in our laboratory (test codes listed below) will no longer report variants in the…
Test Discontinuation Memorandum
Effective immediately, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue test code 4572 – Hypoxanthine-Guanine Phosphoribosyltransferase (HPRT) Enzyme Analysis in red…
Test Consolidation Memorandum
In a continuing effort to provide you with the most straightforward and efficient test ordering process, we are consolidating many of our test codes…
Test Discontinuation Memorandum
Effective November 17, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue the following tests: 2103-CoQ10 Deficiency Deletion/Duplication Panel 2104-CoQ10 Comprehensive…
Test Discontinuation Memorandum
Effective September 15, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue the following tests: 9090 – MAX Sequence Analysis 9025…
Test Discontinuation Memorandum
Effective September 12, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue Test Codes: Test Code: 3788 – LDHA Deletion/Duplication Analysis…
Test Discontinuation Memorandum
Effective September 3, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue the following tests: 9130 – Comprehensive Hereditary Cancer Panel…
Test Discontinuation Memorandum
Effective June 11th, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue the following test: Test Code 2870 – Maple Syrup…
Test Discontinuation Memorandum
Effective April 21, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will discontinue the following tests: Test Code 3105 – Complex IV…
Test Change Memorandum
Effective March 10, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will supplant Test Code 3300 – Autosomal Dominant Progressive External Ophthalmoplegia…
Test Discontinuation Memorandum
This memo is to inform you that the Medical Genetics Laboratories will discontinue the JAK2 R683 Mutation Analysis test effective February 20, 2014. We will…
Test Change Memorandum
Effective January 3, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will supplant Test Code 3500 – Mitochondrial/Metabolic (MitoMet®) Microarray Analysis with…
Test Change Memorandum
Effective January 3, 2014, the Medical Genetics Laboratories at Baylor College of Medicine will supplant test codes 3000, 3005, and 3006 with test code…
Test Discontinuation Memorandum
Effective September 16, 2013 the Medical Genetics Laboratories at Baylor College of Medicine will discontinue offering the following test: Test code 3055 – Mitochondrial…
Test Update Memorandum – FMR1 – Related Disorders Repeat Expansion Analysis
Effective 5/17/2013, the Medical Genetics Laboratories at Baylor College of Medicine will change the methodology for FMR1 – Related Disorders Repeat Expansion Analysis. The…
Test Update Memorandum – White Blood Cell Cystine
The Baylor Medical Genetics Laboratories are constantly striving to improve our services to the clinical community. On March 12, 2013, our biochemical laboratory started…
Test Discontinuation Memorandum
Effective December 15, 2012, the Cancer Genetics Laboratory at Baylor College of Medicine will discontinue the following tests: Test Code 9500 – Cancer Chromosomal…
Test Change Memorandum – Chromosomal Microarray-SNP
What has changed Effective December 1, 2012, the Medical Genetics Laboratories at Baylor College of Medicine will change the array platform for test code…
Test Discontinuation Memorandum
What has changed Effective September 15th, 2012, the Medical Genetics Laboratories at Baylor College of Medicine will no longer offer the following tests: 3050…
Test Change Memorandum – Cystic Fibrosis
What has changed Effective May 1st, 2012, the CFTR-Related Disorders Mutation Panel (Test Code 6014) will be replaced by a new panel with an…
2009-2011 Test Discontinuation Memoranda
July 1, 2011 4512 – Fucosidase Enzyme Analysis – White Blood Cells (WBC) 4513 – Fucosidase Enzyme Analysis – Skin Fibroblast Culture (SFC) 4520…